Metronidazole Extended Release Tablets USP 600 Mg – Metrixol 600 ER Tablets

Metrixol 600 ER Tablets: Metronidazole Extended Release Tablets USP 600 Mg
Composition – Metronidazole 600mg (Extended Release)

Description:
The composition of Metronidazole Extended Release Tablets USP 600 Mg nitroimidazole-class antimicrobial agent with both antiprotozoal and antibacterial effects. It disrupts DNA synthesis in anaerobic organisms and protozoa, leading to cell death. The extended-release formulation ensures prolonged activity, reducing the need for frequent dosing, particularly beneficial in chronic infections such as amoebiasis or bacterial vaginosis.

KEY BENEFITS:
Extended-Release for Better Compliance: Once or twice daily dosing maintains consistent therapeutic levels, enhancing patient adherence in chronic infections.
Potent Anaerobic & Antiprotozoal Action: Effective against Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis, and anaerobic bacteria like Bacteroides.
Reduces Recurrence & Resistance Risk: Extended exposure reduces bacterial load and helps prevent treatment failure or resistance.

Targeted specalists :
GynecologistS
Gastroenterologists
Infectious Disease Specialists

 Disclaimer:
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.